Dai-ichi Life Holdings’s Core Laboratories CLB Stock Holding History

Dai-ichi Life Holdings’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,265	Closed	-$144K	–	570
2015 Q2	$144K	Hold	1,265	–	–	﹤0.01%	632
2015 Q1	$132K	Hold	1,265	–	–	﹤0.01%	630
2014 Q4	$152K	Hold	1,265	–	–	﹤0.01%	618
2014 Q3	$185K	Hold	1,265	–	–	0.01%	617
2014 Q2	$211K	Hold	1,265	–	–	0.01%	595
2014 Q1	$251K	Sell	1,265 -260	-17%	-$49.1K	0.01%	537
2013 Q4	$291K	Hold	1,525	–	–	0.01%	513
2013 Q3	$258K	Hold	1,525	–	–	0.01%	552
2013 Q2	$231K	Buy	+1,525	New	+$216K	0.01%	536

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dai-ichi Life Holdings's CLB Position: Q3 2015 in Review

Dai-ichi Life Holdings sold out of Core Laboratories (CLB) in Q3 2015, closing a stake of 1,265 shares — an estimated $144K sold.

Dai-ichi Life Holdings first reported a position in CLB in Q2 2013 and held it in 9 quarters. The position peaked at $291K in Q4 2013. 352 funds tracked by Wall St. Rank hold CLB as of Q3 2015.

Dai-ichi Life Holdings reported no remaining Core Laboratories position as of Q3 2015 after selling out during the quarter.
Dai-ichi Life Holdings sold 1,265 Core Laboratories shares in Q3 2015, an estimated $144K.
Dai-ichi Life Holdings first reported a position in Core Laboratories in Q2 2013 and held it in 9 quarters.
Dai-ichi Life Holdings's Core Laboratories position peaked at $291K in Q4 2013.
352 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2015.

Based on Dai-ichi Life Holdings's 13F filing for Q3 2015, filed 10 Nov 2015.